FP6Staff exchange2006–2010

CCMST · In vitro techniques for the identification of novel treatment strategies for brain and spinal cord traumatic injury

FP6 — Marie Curie Actions (Human Resources and Mobility)

Duration
2006-12-01 → 2010-11-30
EU contribution
€293,030
Participants
1
Scheme
TOK

Lines connect the coordinator with its partners.

Results in brief

Final Activity Report Summary - CCMST (In vitro techniques for the identification of novel treatment strategies for brain and spinal cord traumatic injury)

The project was designed with the aim of helping researchers in less favoured regions of the EU to increase their competitiveness. This was achieved, among other ways, through the support of visiting researchers who bring useful techniques that are then taught to the host scientists. In the case of the present project, this has been done to understand further changes in the endocannabinoid (EC) system following cerebral insult. Mention the word "cannabis" and most people instantly think of debates as to whether (or not) cannabis should be legalised, or whether (or not) "medical marijuana" has a place in our medical arsenal. The role of cannabinoid system in the body, however, is far more wide-ranging these debates would suggest. The main psychoactive ingredient of cannabis exerts its effects in the body by binding to receiver molecules called CB receptors. There are two types of CB receptors, of which CB1 is of most interest here since it is found in the brain. Of course, the body does not produce CB receptors in the expectation that the host will be exposed to cannabis, but rather as receivers of information conveyed by endogenous molecules, "endocannabinoids". These are involved in processes as diverse as control of pain, appetite and gastrointestinal function. The EC system is believed to act to limit the damage produced by cerebral insults such as trauma and stroke. In order to explore this exciting possibility further, we learnt two techniques, one dealing with tissue culture and the second dealing with the function of CB1 receptors. The latter technique takes advantage of the way in which CB1 receptors associate with other proteins following their activation. We have used this technique to test a hypothesis that a residual deficit in CB1 receptor function (and hence a reduced protection) occurs after oxygen deficit. We found that there is indeed a deficit in the number of receptors, but that the functional response of the receptor population to stimulation was not affected. This is good news, since it means in theory that the EC system can be targeted even following a stroke, to reduce the consequences of a second stroke. Both techniques are generic, i.e. they are not restricted to CB receptors alone but can be applied to other receptors and to other scientific problems. We have started to explore this avenue in different ways, for example in order to see whether an orphan receptor called GPR55 can be activated in its natural state. The term "orphan receptors" designates receptors whose naturally occurring ligands have not been identified. It has been proposed that a lipid called lysophosphatidylinositol is the endogenous activator for GPR55, although most work has been undertaken using artificial systems. We found that the response to lysophosphatidylinositol was negligible in the brain. We have also explored the usefulness of different in vitro cell culture systems to model the blood brain barrier, a naturally occurring defence against brain penetration by toxic compounds. The blood brain barrier is a natural barrier produced by endothelial cells in the brain blood capillaries. The cells are tightly packed, so that many substances cannot enter the brain. However, following cerebral insult, or following exposure to certain toxic substances, the blood brain barrier becomes less effective, and allows the passage of immune cells into the brain, where they can be highly damaging. Our aim was to model in vitro the blood brain barrier, with the aim of using it to identify novel protective molecules in a simple system. Two cultured cell systems were utilised, and both found to be wanting. The first model did not produce a strong enough barrier, whilst the second model, although it produced a good barrier, did not behave in the appropriate manner after the cell cultures were exposed to an agent known to affect barrier function. Although negative, these studies are useful since they give information to researchers about which model systems should not be utilised, thereby allowing the researchers to focus on other, potentially more useful systems.

Data: CORDIS, © European Union

Project objective

Traumatic injury to the brain and spinal cord represents a devastating change in the lives of many individuals. In addition to preventative measures, there is a clear need for early neuroprotective treatment strategies to minimise the damage caused by the traumatic incidencts.Two key aspect of discovering such new treatments are:a) the identification of appropriate targets andb) the use of predictive screening models.With respect to (a),this can be investigated pharmacologically or by the use of molecular biological techniques. With respect to (b),initial studies should use an in vitro system in view of the three Rs (refine, reduce and replace) of animal research. In my laboratory, the hypothesis that compounds preventing the uptake and metabolism of endocannabinoids may be useful neuroprotective agents is being explored.This requires an interdisplicinary approach, provided by collaborations with research groups both within and outside the EU. However, we currently lack two key techniques: a) organotypic cultures from adult rodent brain and spinal cord, in order to study potential neuroprotective agents in a relevant in vitro model, and b) siRNA, to reduce the activity of specific targets in the organotypic cultures when selective inhibitors have not been identified. This proposal uses a time line whereby two experienced researchers are recruited sequentially in order to teach us these techniques. The researchers will participate in the training of designated PhD students and laboratory assistants to ensure effective transfer of knowledge.The techniques will be used initially to determine whether modulation of the endocannabioid system is a potential treatment strategy for limitation of damage after trauma. The techniques, however, are generic and can in combination be applied to evaluate other potential targets at an early stage. This will greatly strengthen our competitiveness and ability to attract talented researchers to a less favoured region of LFRs of EU.

Original text from CORDIS.

Participants

  • Umeä Universitet · UmeåCoordinatorSweden

Links

Data: CORDIS, © European Union